Harold Varmus reflects on the life of John Edward Porter, a House appropriator—and his friend

Porter helped orchestrate the doubling of the NIH budget between 1998 and 2003

On June 3, two days after his 87th birthday, John Edward Porter, who represented the 10th Congressional District of Illinois as a Republican for over twenty years, died of pneumonia in a hospital in Northern Virginia.

Harold Varmus reflects on the life of John Edward Porter, a House appropriator—and his friend

ARPA-H placed outside NIH in authorization bill approved in a 336-85 House vote

NCI strategy for evaluating MCED assays may bypass cancer clinical trials groups

NCI BSA approves eight new, nine reissued concepts

Survivor Stories: Rob Krigel, Nedra Bonds, Stacey Smith

Transforming the future of radiation oncology:
Three ways collaboration accelerates FLASH radiation therapy research

In Brief

Alex A. Adjei named chair of Cleveland Clinic Taussig Cancer Institute

Joe W. Ramos named director of Louisiana Cancer Research Center

McKesson, HCA Healthcare to form oncology research joint venture

ESOP-ECO survey reveals cancer drug shortages in countries surrounding Ukraine

Dana-Farber establishes Lubin Family Foundation Scholar Awards

“Cecilie,” statue of a woman with incurable breast cancer, unveiled in Norway

Texas Oncology breaks ground on comprehensive cancer center in Beaumont

Clinical Roundup

ACS study: Cancer survivors have grown to 18 million in the U.S.

Winship study: COVID-19 vaccines much less effective for patients with NHL/CLL

UTSW researchers develop blood test to predict liver cancer risk

Cedars-Sinai study: Targeting IL-27 signaling pathway may help develop immunotherapies for HCC

Drugs & Targets

FDA grants accelerated approval to Tafinlar + Mekinist in unresectable or metastatic solid tumors with BRAF V600E mutation

FDA grants Fast Track designation to IK-930 in unresectable NF2-deficient mesothelioma

Cullinan Oncology, Taiho Pharmaceuticals complete agreement to develop and commercialize CLN-081/TAS6417

FDA orders JUUL products removed from U.S. markets

Recent Issues

Renew today!

Subscriber content

Can you spare 10 minutes to complete a survey?

Login